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SNAPApoptotic signaling plays an important role in skeletal muscle degradation, atrophy, and dysfunction. Mitochondria
are central executers of apoptosis by directly participating in caspase-dependent and caspase-independent cell
death signaling. Given the important apoptotic role ofmitochondria, alteringmitochondrial content could inﬂuence
apoptosis. Therefore, we examined the direct effect of modest, but physiological increases in mitochondrial biogen-
esis and content on skeletalmuscle apoptosis using a cell culture approach. Treatment of L6myoblastswith SNAP or
AICAR (5 h/day for 5 days) signiﬁcantly increased PGC-1, AIF, cytochrome c, andMnSOD protein content as well as
MitoTracker staining. Following induction ofmitochondrial biogenesis, L6myoblasts displayed decreased sensitivity
to apoptotic cell death as well as reduced caspase-3 and caspase-9 activation following exposure to staurosporine
(STS) and C2-ceramide. L6 myoblasts with higher mitochondrial content also exhibited reduced apoptosis and AIF
release following exposure to hydrogen peroxide (H2O2). Analysis of several key apoptosis regulatory proteins
(ARC, Bax, Bcl-2, XIAP), antioxidant proteins (catalase, MnSOD, CuZnSOD), and reactive oxygen species (ROS)mea-
sures (DCF and MitoSOX ﬂuorescence) revealed that these mechanisms were not responsible for the observed cel-
lular protection. However, myoblasts with higher mitochondrial content were less sensitive to Ca2+-induced
mitochondrial permeability transition pore formation (mPTP) and mitochondrial membrane depolarization.
Collectively, these data demonstrate that increased mitochondrial content at physiological levels provides protec-
tion against apoptotic cell death by decreasing caspase-dependent and caspase-independent signaling through
inﬂuencing mitochondrial Ca2+-mediated apoptotic events. Therefore, increasing mitochondrial biogenesis/
contentmay represent a potential therapeutic approach in skeletalmuscle disorders displaying increased apoptosis.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is a critical process for normal development; however,
dysregulation can occur in disease states [1–3]. In skeletal muscle,
apoptotic signaling plays an important role in muscle degradation,
atrophy, and dysfunction [4]. Apoptosis can be triggered by many
different stimuli but execution occurs predominantly through several
pathways (i.e., death receptor, mitochondrial, and ER-stress) [5–7].
Mitochondria are the central executers of apoptosis given that they
directly participate in cell death signaling through the well character-
ized mitochondrial pathway, but are also the converging point of
several other apoptotic signaling cascades [6]. Mitochondrial outer
membrane permeabilization (MOMP) can occur following cellular
stress, which can result in the release of apoptogenic factors
(e.g., cytochrome c, Smac) into the cytosol [8]. Release of cytochrome
c can ultimately lead to activation of proteolytic enzymes known as
caspases (caspase-3 and caspase-9) [9]. In the cytosol, Smac canniversity of Waterloo, Waterloo,
19 885 0470.
ro).
l rights reserved.also promote caspase activation by inhibiting XIAP [10]; an important
caspase-3 and -9 inhibitor protein [11]. In addition to caspase-
mediated events, there are caspase-independent mechanisms initiat-
ed at the mitochondria. For example, apoptosis inducing factor (AIF)
can be released from the mitochondria and translocate to the nucleus
to induce DNA fragmentation and chromatin condensation directly
without caspase activation [12,13].
Given the importance of mitochondria in apoptotic signaling, it is
reasonable to assume that altering mitochondrial content or function
could have a dramatic effect on cell death. Mitochondrial biogenesis
is a complex process that can be activated through a number of
mechanisms. Peroxisome proliferator-activated receptor (PPAR)-γ
coactivator-1α (PGC-1α) has been shown to be one of the main reg-
ulators of mitochondrial biogenesis by increasing many transcription
factors (e.g., NRF-1, NRF-2, Tfam) involved in the expression of both
nuclear- and mitochondrial-encoded genes essential for this process
[14]. For example, overexpression of PGC-1α in mouse myoblasts
leads to signiﬁcantly higher gene expression of cytochrome c,
COXIV, COXII, elevated mitochondrial DNA copy number, and
increased mitochondrial volume [15].
Currently, the direct role of altered mitochondrial content (at
physiological levels) on apoptotic signaling in skeletal muscle is
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muscle mitochondrial biogenesis and content show decreased apo-
ptotic signaling and apoptosis, whereas conditions with decreased
mitochondrial content demonstrate the opposite. For example, regu-
lar exercise training can increase mitochondrial content in skeletal
muscle [16] and has been associated with lower levels of DNA frag-
mentation and/or apoptotic signaling [4,17–20]. In contrast, muscle
inactivity has been shown to cause decreased mitochondrial content
[21,22]; a condition associated with increased apoptosis/apoptotic
signaling [23,24]. Similarly, caloric restriction can induce skeletal
muscle mitochondrial biogenesis [25,26] and decreased apoptosis
[27,28], whereas aging is associated with decreased skeletal muscle
mitochondrial content [29,30] and increased levels of apoptosis
[24,31]. Thus, the purpose of this project was to speciﬁcally examine
the direct effect of modest, but physiological changes in mitochondri-
al biogenesis and content on skeletal muscle apoptosis using a cell
culture approach. To accomplish this, L6 myocytes were cultured
under several conditions to induce mitochondrial biogenesis and
then exposed to several apoptotic stimuli.
2. Materials and methods
2.1. Cell culture and treatments
L6 rat myoblasts were cultured in low glucose Delbecco's Modiﬁed
Eagles Medium (DMEM; Hyclone) containing 10% fetal bovine serum
(Hyclone) and 1% penicillin and streptomycin (Hyclone) on polystyrine
cell culture dishes (BD Biosciences). Cells were used between passages
3 and 10. Cells were allowed to adhere to the dish surface and grow for
24 h at which point cells were washed with Ca2+- and Mg2+-free
phosphate buffered saline (PBS) and media replaced. Cells were
cultured in the absence of drugs (CTRL) or with 100 μM of the nitric
oxide (NO) donor, S-nitroso-N-acetylpenicillamine (SNAP; Invitrogen),
or 2 mM of the AMPK activator, 5-Aminoimidazole-4-carboxamide-
ribonucleoside (AICAR; Toronto Research Chemicals). Nitric oxide do-
nors and AICAR have been previously used to induce mitochondrial
biogenesis in a number of cells including skeletal myocytes [32,33].
Drugs were administered to cultured cells for 5 h per day for 5 days.
After each 5 hour treatment period, media was aspirated, cells washed
with PBS, and freshmedia replaced. Each experimentwas performed in
duplicate on at least 3 separate occasions (see ﬁgure captions for
details).
2.2. Induction of apoptosis
Cells remained untreated or exposed to staurosporine (STS), hy-
drogen peroxide (H2O2), or C2-ceramide; agents that have previously
been shown to induce apoptosis [34,35]. STS was administered at
a concentration 2 μM for 4 h, while H2O2 and C2-ceramide were
administered at concentrations of 2 mM and 50 μM, respectively,
for 24 h. Following administration, cells were harvested as appropri-
ate for the various procedures outlined below.
2.3. DNA fragmentation assay
As a conﬁrmation of downstream apoptotic induction, cells were
analyzed for DNA fragmentation using the Cell Death Detection
ELISAPLUS Kit (Roche Diagnostics) as previously described [19,36].
Brieﬂy, cells were incubated in lysis buffer and then centrifuged at
200 g for 10 min at room temperature. Supernatant was incubated
for 2 h at room temperature with anti-histone-biotin/anti-DNA-POD
reagent in a streptavidin coated microplate under gentle shaking. The
wells were washed several times and ABTS substrate solution was
added. The absorbance was measured at 405 nm and 490 nm using a
SPECTRAmax Plus spectrophotometer (Molecular Devices). Absor-
bance was normalized to total protein content and expressed as AUper mg protein. Compared to untreated myoblasts (1.0 ± 0.2 AU/mg
protein), a several fold increase in DNA fragmentation was observed
following 4 h exposure to 2 μM STS (71.4 ± 1.0 AU/mg protein),
24 h exposure to 2 mM H2O2 (11.6 ± 2.5 AU/mg protein), and 24 h
exposure to 50 μM C2-ceramide (3.4 ± 0.6 AU/mg protein).
2.4. Cell counts and cell size analysis
Cell counts were performed using the Z2 Coulter Counter (Beckman-
Coulter). The majority of cells typically appeared at a cell size ranging
from 10 to 18 μm. As a gross measure of cell death/apoptotic processes,
a second count was performed between 5 and 10 μm. The quantity of
these small cells (apoptotic) was expressed as a percentage of the
total cell population.
2.5. Flow cytometry analysis for mitochondrial content, ROS generation,
annexin V/PI staining, mitochondrial membrane potential, mitochondrial
permeability transition pore formation
All ﬂow cytometry analyses were performed on forward and side
scatter gated populations. Mitochondrial content was determined
using the ﬂuorescent probe MitoTracker Green (Invitrogen). Brieﬂy,
cells (5 × 105) were resuspended in PBS containing 100 nM
MitoTracker Green (Invitrogen) in the dark for 15 min at 37 °C. Cells
were washed with PBS, and ﬂuorescence measured by a ﬂow
cytometer (FACSCalibur; BD Bioscience) equipped with Cell Quest Pro
software (BD Bioscience).
Total cellular reactive oxygen species (ROS) generation was deter-
mined using 2′,7′-dichlorohydroﬂuorescein-diacetate (DCFH-DA).
DCFH-DA is hydrolyzed by intracellular esterases to yield the
nonﬂuorescent DCFH. DCFH is then oxidized by cellular ROS to the
highly ﬂuorescent compound DCF. Brieﬂy, cells (5 × 105) were
resuspended in PBS containing 10 μM DCFH-DA (Invitrogen) and
incubated in the dark for 15 min at 37 °C. Cells were washed with
PBS, and DCF ﬂuorescence measured by ﬂow cytometry.
Mitochondrial superoxide generation was determined using the
highly selective mitochondrial dye, MitoSOX Red. Brieﬂy, cells
(5 × 105) were resuspended in PBS containing 5 μM of MitoSOX Red
(Invitrogen) and incubated in the dark at 37 °C for 30 min. Cells were
then centrifuged and washed twice with PBS, and ﬂuorescence mea-
sured by ﬂow cytometry.
Annexin V-FITC is a ﬂuorescent protein that binds to
phosphatidylserine that appears on the plasma membrane during ap-
optosis. Propidium iodide (PI) is a ﬂuorescent dye that binds to nucle-
ar DNA following rupture of the plasma membrane. Cells (1 × 105)
were resuspended in Annexin Binding Buffer (10 mM HEPES/NaOH,
pH 7.4, 150 mM NaCl, 1.8 mM CaCl2) and incubated in the dark for
15 min at room temperature with 5 μL of Annexin V-FITC and 10 μL
of PI (50 μg/mL), after which 400 μL of Annexin Binding Buffer was
added. Annexin V-FITC and PI ﬂuorescence were measured by ﬂow
cytometry.
A decrease in mitochondrial membrane potential is a common ap-
optotic event that can be monitored by changes in the JC-1 red:green
ﬂuorescence ratio, where a decreased ratio is indicative of mitochon-
drial membrane depolarization [6,37]. Brieﬂy, cells (2.5 × 105) were
incubated with 2 μM JC-1 in HBSS (1.26 mM CaCl2, 0.49 mM MgCl2,
0.41 mM MgSO4, 5.33 mM KCl, 0.44 mM KH2PO4, 4.17 mM NaHCO3,
137.93 mM NaCl, 0.34 mM Na2HPO4, 5.56 mM Dextrose, pH 7.4) in
the presence of 5 μM, 10 μM, and 20 μM of the Ca2+ ionophore
A23187 for 15 min at 37 °C. Cells were washed by centrifugation at
1000 g for 5 min and resuspended in 500 μl HBSS for ﬂow cytometry
analysis. As a positive control, 50 μM CCCP was used to induce
membrane depolarization.
Mitochondrial permeability transition pore (mPTP) formation is a
key event that occurs during mitochondrial-mediated apoptosis
which is responsible for mitochondrial apoptogenic protein release
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compartments including the mitochondria. In the presence of cobalt,
ﬂuorescence is restricted to the mitochondria given that the mito-
chondrial matrix is impermeable to cobalt. During membrane perme-
abilization, cobalt gains access to the mitochondrial matrix thereby
quenching the ﬂuorescent signal. Thus a decrease in calcein ﬂuores-
cence is indicative of mPTP formation. Brieﬂy, cells (2.5 × 105) were
incubated with 1 μM calcein AM and 1 mM CoCl2 in HBSS in the pres-
ence of 5 μM, 10 μM, and 20 μM of the Ca2+ ionophore A23187 for
15 min at 37 °C. Cells were washed by centrifugation at 2000 g for
10 min and resuspended in 500 μl HBSS for ﬂow cytometry analysis.
2.6. Isolation of cytosolic- and mitochondrial-enriched fractions
Cells were separated into cytosolic- and mitochondrial-enriched
fractions using differential centrifugation [38–40]. Brieﬂy, an equal
number of cells (1 × 106) were incubated in digitonin buffer (PBS
with 250 mM sucrose, 80 mM KCl, and 5 mg/mL digitonin) (Sigma-
Aldrich) for 5 min on ice. Cells were centrifuged at 1000 g for
10 min, the supernatant was collected and centrifuged at 16,000 g
for 10 min to pellet cells, debris, or mitochondrial contamination.
The resulting supernatant was collected and stored as the cytosolic-
enriched fraction. The original pellet was washed in PBS and
centrifuged at 1000 g for 5 min, resuspended in lysis buffer (20 mM
HEPES, 10 mM NaCl, 1.5 mM MgCl, 1 mM DTT, 20% glycerol and 0.1%
Triton X100; pH 7.4), and incubated on ice for 5 min. The tube was
then centrifuged at 1000 g for 10 min, the supernatant was collected
and centrifuged an additional time (1000 g for 10 min), with the
resulting supernatant stored as the mitochondrial-enriched fraction.
AIF expression in mitochondrial and cytosolic fractions was deter-
mined by immunoblot analysis.
2.7. Analysis of total cellular protein content
Total cell lysates were prepared in lysis buffer (as above) containing
protease inhibitors (Complete Cocktail; Roche Diagnostics). Samples
were then hand homogenized using a plastic homogenizer, and
sonicated for 20 s. Total protein content was determined by the BCA
protein assay.
2.8. Immunoblot analysis
Immunoblot analysis was completed as previously described
[36,38]. Membranes were incubated at room temperature for 1 h or
overnight at 4 °C with primary antibodies against: apoptosis inducing
factor (AIF), apoptosis repressor with caspase recruitment domain
(ARC), Bax, Bcl-2, cytochrome c, PGC-1 (Santa Cruz Biotechnology),
copper zinc superoxide dismutase (CuZnSOD), manganese superox-
ide dismutase (MnSOD), x-linked inhibitor of apoptosis protein
(XIAP) (Enzo Life Sciences), and catalase (Chemicon). Bands were
visualized using Enhanced Chemiluminescence Western Blotting
Detection Reagents (GE Healthcare) and the Chemi Genius 2 Bio-
Imaging System (Syngene). The approximate molecular weight for
each protein was estimated using Precision Plus Protein WesternC
Standards and Precision Protein Strep-Tactin HRP Conjugate (Bio-Rad
Laboratories). Equal loading and quality of transfer was veriﬁed by
staining membranes with Ponceau S (Sigma-Aldrich). Protein levels
were expressed as mean optical density in arbitrary units (AU).
2.9. Caspase activity assay
Cell lysates prepared in ice-cold muscle lysis buffer not containing
protease inhibitors were incubated in duplicate with the ﬂuorescent
substrate Ac-DEVD-AMC (Enzo Life Sciences) for determination of
caspase-3 activity, or Ac-LEHD-AMC (Enzo Life Sciences) for determi-
nation of caspase-9 activity [36,38]. These substrates are weaklyﬂuorescent but ﬂuorescence increases dramatically following proteo-
lytic cleavage by their corresponding active caspase. Fluorescence
was measured using a SPECTRAmax Gemini XS microplate spectroﬂu-
orometer (Molecular Devices) with excitation and emission wave-
lengths of 360 nm and 440 nm, respectively. Caspase activity was
expressed as mean ﬂuorescence intensity in AU per mg protein.
2.10. Statistical analysis
Statistical comparisons were made between CTRL and treatment
groups using paired Student's t-tests. Differences were considered
statistically signiﬁcant when p b 0.05. Values are expressed as
means ± SEM.
3. Results
3.1. Mitochondrial biogenesis
The protein expression of several mitochondrial content/biogenesis-
associated markers was assessed in myoblasts following SNAP and
AICAR treatment. SNAP administration increased the protein content
of PGC-1 (34%; p b 0.05), AIF (19%; p b 0.05), cytochrome c (20%;
p b 0.05), and MnSOD (22%; p b 0.05) relative to CTRL myoblasts
(Fig. 1A). Similarly, AICAR administration increased the protein content
of PGC-1 (36%; p b 0.01), AIF (19%; p b 0.05), cytochrome c (72%;
p b 0.05), and MnSOD (26%; p b 0.05) relative to CTRL myoblasts
(Fig. 1A). Additional experiments performed by ﬂow cytometry analysis
using the mitochondrial dye MitoTracker Green conﬁrmed a signiﬁcant
increase in mitochondrial content in both SNAP (18%; p b 0.05) and
AICAR (22%; p b 0.05) treated myoblasts (Fig. 1B).
3.2. Cell size analysis
As an initial indicator of cell health, we measured the decrease in
cell size, as this is a hallmark of apoptosis. Healthy cells generally
fell in a range between 10 and 18 μm whereas the population of
smaller cells below this range increased following treatment with
apoptosis-inducing agents. In order to exclude very small particles
we assessed smaller cells by setting a threshold between 5 and
10 μm. The proportion of small cells increased following treatment
with STS (52.6%), H2O2 (30.3%) and C2-ceramide (32.0%) compared
to the untreated condition (19.5%). However, there were 6.1%
(p b 0.05), and 4.8% (p b 0.001) fewer of these smaller myoblasts fol-
lowing H2O2 and C2-ceramide exposure in cells treated with SNAP.
Similarly, there were 4.8% (p b 0.05), and 5.0% (p b 0.001) fewer of
these smaller myoblasts following H2O2 and C2-ceramide exposure,
respectively, in myoblasts treated with AICAR. Although AICAR and
SNAP decreased the number of these smaller cells following STS
exposure (by 1–2%), this was similar to the response observed in
SNAP and AICAR treated cells in the basal condition (in the absence
of apoptosis-inducing agents).
3.3. Phosphatidylserine externalization and propidium iodide staining
As a more sensitive measure of cell death events, we measured the
level of Annexin V and PI staining. There were no differences in the
percentage of healthy (Annexin V−/PI−), early apoptotic (Annexin
V+/PI−), or late apoptotic (Annexin V+/PI+) cells in untreated myo-
blasts compared to those administered SNAP or AICAR in the absence
of apoptotic stimuli. Treatment of myoblasts with STS, H2O2, or
C2-ceramide signiﬁcantly decreased the percentage of healthy cells
while increasing cell death compared to untreated cells (Fig. 2). Inter-
estingly, this response was inﬂuenced by SNAP and AICAR treatment.
In particular, signiﬁcantly more of the SNAP (64%; p b 0.05) and
AICAR (70%; p b 0.005) treated myoblasts were Annexin V-/PI- com-
pared to CTRL (54%) myoblasts following STS exposure (Fig. 2A).
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Fig. 1.Markers of mitochondrial biogenesis/content following SNAP and AICAR administration in L6 myoblasts. Representative immunoblots and quantitative analysis of PGC-1, AIF,
cytochrome c, and MnSOD protein in untreated (CTRL), as well as SNAP and AICAR treated L6 cells (Panel A). Quantitative analysis of MitoTracker Green ﬂuorescence in untreated
(CTRL), as well as SNAP and AICAR treated L6 cells (Panel B). Values are means ± SEM (n = 5–8). ⁎, signiﬁcantly different compared to untreated (CTRL) cells (p b 0.05). †,
signiﬁcantly different compared to untreated (CTRL) cells (p b 0.01).
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myoblasts compared to CTRL myoblasts following exposure to H2O2
and C2-ceramide (Fig. 2A).
In line with this data, signiﬁcantly fewer SNAP (24%; p b 0.05) and
AICAR (18%; p b 0.01) treated myoblasts were Annexin V+/PI− (early
apoptotic) compared to CTRL (31%) myoblasts following STS expo-
sure (Fig. 2B). Similar protective effects were observed in SNAP and
AICAR treated compared to CTRL myoblasts following exposure to
H2O2 or C2-ceramide (Fig. 2B). The percentage of Annexin V+/PI+
(late apoptotic) cells was also lower in SNAP (p b 0.05) and AICAR
(p b 0.05) treated myoblasts following STS exposure, and SNAP
(p = 0.06) and AICAR (p b 0.01) treated myoblasts following
C2-ceramide exposure compared to CTRL myoblasts (Fig. 2C).
3.4. Proteolytic enzyme activity
To examine the signaling mechanisms involved in the observed
apoptotic responses, we measured the activity of several caspases.
Caspase-3 is a key executioner proteolytic enzyme activated during
apoptosis, whereas caspase-9 is the initiator proteolytic enzyme acti-
vated during mitochondrial-mediated caspase-dependent apoptotic
events. There was no difference in the activity of caspase-3 or
caspase-9 in myoblasts treated with SNAP or AICAR compared to
untreated myoblasts in the absence of apoptotic stimuli. Treatment
of myoblasts with STS or C2-ceramide increased caspase-3 and
caspase-9 activity; responses that were inﬂuenced by SNAP and
AICAR treatment. Compared to CTRL myoblasts, SNAP and AICAR
treated myoblasts had 16% (p b 0.05) and 27% (p b 0.05) lower
caspase-3 activity, respectively, following STS exposure. In addition,
SNAP and AICAR treated myoblasts had 19% (p b 0.01) and 17%
(p b 0.005) lower caspase-3 activity, respectively, compared to CTRL
myoblasts following C2-ceramide exposure (Fig. 3A). Similarly,A B
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Fig. 2. Phosphatidylserine (Annexin V) and propidium iodide (PI) staining in L6 myoblasts fol
V−PI−) untreated (absence of apoptotic stimuli), STS, H2O2, and C2-ceramide treated L6 myob
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pared to CTRL (p b 0.01). ‡, signiﬁcantly different compared to CTRL (p b 0.005). §, signiﬁcantSNAP and AICAR treated myoblasts had 18% (p b 0.001) and 20%
(p b 0.05) lower caspase-9 activity, respectively, following STS expo-
sure. SNAP treatedmyoblasts also had 17% (p b 0.05) lower caspase-9
activity following C2-ceramide exposure compared to CTRL myo-
blasts (Fig. 3B). Interestingly, H2O2 exposure resulted in the lowest
caspase activation of all apoptosis-inducing agents, with no signiﬁ-
cant differences observed between groups in both caspase-3 and
caspase-9 activity.
3.5. Caspase-independent signaling via AIF release
Given the relatively low caspase-9 and caspase-3 activation fol-
lowing H2O2 treatment despite an increase in apoptotic cells, along
with the lack of decline in these proteolytic enzymes in SNAP and
AICAR treated myoblasts despite their protective effect on apoptosis,
we investigated AIF release as it can mediate apoptosis in a caspase-
independent manner. There was no difference in AIF release (as
evident by cytosolic AIF) in untreated myoblasts compared to those
administered SNAP or AICAR in the absence of apoptotic stimuli.
Relative to untreated cells, there was minimal AIF release in STS and
C2-ceramide treated cells (Fig. 4), indicating that caspase-mediated
mechanisms are the primary means of apoptotic induction by these
agents. In contrast, we observed a large release of AIF in H2O2 treated
myoblasts (Fig. 4). In agreement with this ﬁnding, we observed a
prominent second immunoreactive AIF band in the mitochondrial
fraction that migrated at a lower molecular weight in cells treated
with H2O2, but not in STS or C2-ceramide treated cells (Fig. 4). The
molecular weight (~57 kDa) of this second band was consistent
with that of the cytosolic (released) AIF. This is in agreement with
the mitochondrial processing of AIF observed during apoptosis. Inter-
estingly, SNAP and AICAR treated myoblasts had 23% (p b 0.05) and
18% (p b 0.05) lower levels of cytosolic AIF, respectively (Fig. 4).C
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Fig. 3. Proteolytic enzyme activity in L6 myoblasts following exposure to apoptosis-inducing stimuli. Quantitative analysis of caspase-3 activity in untreated (absence of apoptotic
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We next examined the expression of several key anti-apoptotic and
pro-apoptotic proteins to further evaluate the signaling mechanisms in-
volved in the apoptotic protection observed. The expression of ARC,
Bcl-2, Bax, and XIAP were not signiﬁcantly different in untreated
compared to SNAP and AICAR treated cells in the absence of apoptotic
stimuli (data not shown). Although ARC protein expression was lower
following exposure to STS and H2O2 compared to untreated cells, few
signiﬁcant changes were observed across treatment groups (Fig. 5A–
C). Compared to untreated cells, Bcl-2 protein expression was elevated
in myoblasts exposed to H2O2 and C2-ceramide, but not STS. Few signif-
icant differences were observed in Bcl-2 protein expression across treat-
ment groups (Fig. 5A–C). Bax protein expression tended to be higher
following STS and H2O2 exposure but was not different between groups.
Bax protein expression was not different following C2-ceramide expo-
sure, as well as across groups (Fig. 5A–C). XIAP protein was lower fol-
lowing STS, H2O2, and C2-ceramide exposure compared to untreated
cells. Following STS exposure, XIAP protein in AICAR treated cells was
signiﬁcantly (p b 0.05) higher compared to CTRL cells. In contrast,
XIAP protein in both SNAP and AICAR treated cells was signiﬁcantly
(p b 0.05) lower compared to CTRL cells following C2-ceramide expo-
sure. No differences between groups were noted in XIAP protein follow-
ing H2O2 exposure (Fig. 5A–C).
3.7. Antioxidant protein expression and ROS generation
To examine if altered redox signaling mechanisms were involved
in the observed apoptotic changes, we evaluated antioxidant protein50kDa
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p b 0.05) treated myoblasts compared to untreated myoblasts (data
not shown). Although catalase protein content was higher following
H2O2 exposure, no differences were noted following exposure to
any apoptosis-inducing agent compared to untreated cells, as well
as across treatment conditions (Fig. 6A–C). Although CuZnSOD pro-
tein expression was lower following C2-ceramide exposure, no differ-
ences were noted following exposure to any apoptosis-inducing
agent compared to untreated cells, and few differences were ob-
served across treatment conditions (Fig. 6A–C). As demonstrated in
Fig. 1, MnSOD protein content was elevated following SNAP and
AICAR administration compared to untreated control cells. Although
MnSOD protein was lower following H2O2 exposure, MnSOD protein
was unchanged following exposure to STS and C2-ceramide com-
pared to untreated myoblasts, as well as across treatment conditions
regardless of the apoptosis-inducing agent (Fig. 6A–C).
Total cellular ROS was determined with the ROS-reactive dye,
DCFH-DA, and measured by ﬂow cytometry. There was no difference
in DCF ﬂuorescence in SNAP or AICAR treated myoblasts compared to
untreated cells (data not shown). Following exposure to STS and H2O2,
DCF ﬂuorescence was generally lower, but was not altered in re-
sponse to C2-ceramide exposure (Fig. 6D). There were few differ-
ences in ROS generation when comparing CTRL to SNAP or AICAR
treated cells following exposure to STS, H2O2, and C2-ceramide. Mito-
chondrial speciﬁc ROS production was evaluated by ﬂow cytometry
using a highly selective mitochondrial superoxide indicator dye,
MitoSOX Red. There was no difference in MitoSOX ﬂuorescence in
SNAP or AICAR treated myoblasts compared to untreated cells (dataCytosolic
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cence following exposure to STS, H2O2, and C2-ceramide, as well as
across treatment groups (Fig. 6E).
3.8. Ca2+-induced mitochondrial membrane depolarization and
permeability transition pore (mPTP) formation
To further determine the mechanisms responsible for the observed
apoptotic protection; we examined several factors associated with
mitochondrial function and apoptotic signaling following exposure to
a Ca2+ overload. Treatment of cells with increasing concentrations of
the Ca2+ ionophore A23187 reduced JC-1 red:green ﬂuorescence
ratio (indicative of mitochondrial membrane depolarization). In gener-
al, SNAP and AICAR treated myoblasts maintained a higher membrane
potential compared to CTRL cells (Fig. 7A). Although mitochondrial
membrane depolarization occurs in a number of apoptotic states, its
time course is very rapid and it is not necessarily indicative of mem-
brane permeabilization [6,41,42]. Therefore, as a more speciﬁc measure
we determined mPTP formation following Ca2+ overload using thecalcein-cobalt assay. Treatment of cells with increasing concentrations
of A23187 reduced mitochondrial calcein ﬂuorescence (indicative of
mPTP formation). Interestingly, SNAP and AICAR treated cells displayed
signiﬁcantly (p b 0.05) less of a decrease in calcein ﬂuorescence
compared to CTRL cells following A23187 treatment (Fig. 7B).
4. Discussion
To better understand the effect of increased mitochondrial content
on apoptosis susceptibility, we induced mitochondrial biogenesis via
several different chemical approaches and exposed cells to three differ-
ent apoptosis-inducing agents. We demonstrate that treatment with
the NO donor, SNAP and the AMPK activator, AICAR (both for 5 h/day
for 5 days) results in a modest activation of mitochondrial biogenesis,
as evident by increased PGC-1 protein content, as well as a modest in-
crease in mitochondrial content, as evident by the higher MitoTracker
Green ﬂuorescence and expression of mitochondrial-speciﬁc proteins
(cytochrome c, AIF, and MnSOD). These increases in mitochondrial
content are in agreement with previous work in skeletal muscle
AB
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caloric restriction [25,45,46]. Overall, we feel that the modest increase
in mitochondrial content achieved in our in vitro model nicely reﬂect
mitochondrial biogenesis at physiological levels.The main ﬁnding of this study was that chemical-induced mito-
chondrial biogenesis by two different drugs has a protective effect
against stress-induced myoblast cell death by altering apoptosis-
speciﬁc mechanisms. More importantly, increasing mitochondrial
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of cell death which mediate their effects through different apoptotic
signaling cascades. However, increased mitochondrial content had
no inﬂuence on basal myoblast cell death. The apoptotic resistant
phenotype observed in the present study is consistent with previous
work in models that display increased mitochondrial content. For
example, we recently found that 6 weeks of treadmill running can in-
crease mitochondrial content in normotensive (WKY) and spontane-
ously hypertensive rats (SHR). Interestingly, this was associated with
decreased DNA fragmentation (a hallmark of apoptosis) in skeletal
muscle of SHR but not WKY rats, suggesting that this beneﬁcial effect
is observed during times of increased cellular stress [19]. Wenz et al.
[47] found that muscle-speciﬁc mitochondrial biogenesis through
PGC-1α overexpression had little effect on skeletal muscle DNA frag-
mentation in younger animals (when DNA fragmentation was low);
however, was protective in older animals as DNA fragmentation in-
creased. Consistent with this ﬁnding, Song et al. [18] found that exer-
cise training had no effect of skeletal muscle DNA fragmentation in
young rats but signiﬁcantly reduced the age-related increase in DNA
fragmentation. Taken together, our results provide strong in vitro
evidence that increased mitochondrial content can prevent stress-
induced apoptosis in skeletal muscle.
To elucidate the mechanism of apoptotic protection following
mitochondrial biogenesis, we examined the activity of proteolytic
enzymes involved in apoptotic signaling. Speciﬁcally, we measured
the activity of caspase-3 and caspase-9, which can be activated by the
mitochondrial pathway of apoptosis. Previous work in L6 myotubes
has shown that exposure to C2-ceramide elevates caspase-3 activity
[48]. Similarly, Cámara et al. [49] demonstrated that STS administration
caused caspase-3 and -9 activation in L6E9 myoblasts. As expected, STS
and C2-ceramide treatment signiﬁcantly increased the activity of
caspase-3 in our L6 myoblasts. Interestingly, the increase in caspase-3
activity following STS and C2-ceramide exposure was attenuated in
cells treated with SNAP and AICAR. In agreement with this, the activity
of the initiator caspase, caspase-9, was signiﬁcantly attenuated in both
SNAP and AICAR groups following STS exposure, as well as in SNAP
treated cells following C2-ceramide administration. Taken together,
these results suggest that increased mitochondrial content can protect
skeletal myoblasts against mitochondrial-mediated apoptotic cell
death acting through caspase-dependent mechanisms.
Despite the increase in myoblast apoptosis following exposure to
H2O2, there were only small increases in caspase-3 and caspase-9 ac-
tivity. These ﬁndings suggested an alternative mechanism of apopto-
tic death following H2O2 exposure, thus we investigated caspase-
independent signaling events by examining the release of AIF from
the mitochondria. Previous studies using various cell types have
shown that H2O2 exposure leads to caspase-independent apoptosis,which is mediated by AIF release [50,51]. Once released, AIF can trans-
locate to the nucleus to induce DNA cleavage [12,13], which is consis-
tent with our data showing elevated DNA fragmentation following
H2O2 exposure. In addition, recent work from our lab found that AIF re-
lease is an important mechanism mediating skeletal muscle apoptosis
in vivo in response to elevated skeletal muscle reactive oxygen species
(ROS) and oxidative stress [36]. In this present study we found that cy-
tosolic AIF levels dramatically increased in cells treated with H2O2, but
not following STS or C2-ceramide exposure. Interestingly, in the mito-
chondrial fraction, all samples expressed a ~62 kDa band; however,
cells treated with H2O2 also displayed a prominent ~57 kDa AIF iso-
form, which is consistent with the molecular weight of the AIF band
that appeared in the cytosolic fractions. Previous reports have shown
that the ~62 kDa band represents a mature AIF form, whereas the
~57 kDa band is a cleaved isoform [52,53]. Consistent with our H2O2
data, it has been demonstrated that in response to ROS formation AIF
becomes oxidized and modiﬁed, allowing for more efﬁcient cleavage
by calpains and release from mitochondria [54]. Our results also dem-
onstrate that induction of mitochondrial biogenesis not only reduced
AIF release, but protected against H2O2-mediated myoblast apoptosis.
Collectively, our data demonstrate that STS and C2-ceramide mediate
apoptosis through a caspase-dependent mechanism, while H2O2 acts
via a separate, caspase-independent mechanism. Therefore, increasing
mitochondrial content protects against both caspase-dependent and
-independent apoptotic cell death.
To help explain the apoptotic resistant phenotype following
induction of mitochondrial biogenesis, we examined total cellular
protein content of key apoptosis-associated regulatory proteins.
Induction of mitochondrial biogenesis was not associated with any
signiﬁcant differences in the protein content of the anti-apoptotic
proteins, ARC, Bcl-2, and XIAP as well as the pro-apoptotic protein,
Bax. While there were some differences in the levels of these
proteins following exposure to apoptotic agents, these changes gen-
erally did not support the anti-apoptotic phenotype observed.
Therefore, our results indicate that the enhanced resistance to apo-
ptotic stimuli in L6 myoblasts following an increase in mitochondri-
al content is not likely due to changes in pro- and anti-apoptotic
protein content.
Several conditions associated with increased mitochondrial con-
tent also inﬂuence cellular redox status. For example, caloric restric-
tion in vitro [55] and in vivo [56] reduces ROS generation. Similarly,
regular exercise training has been shown to reduce mitochondrial
H2O2 release [57,58]. PGC-1 has also been shown to be important in
antioxidant expression and potentially oxidative stress [59]. For ex-
ample, skeletal muscle-speciﬁc PGC-1α overexpression increases
MnSOD protein and catalase activity while reducing muscle protein
oxidation [47]. In contrast, heart and brain tissue of PGC-1α null
3434 A.D. Dam et al. / Biochimica et Biophysica Acta 1833 (2013) 3426–3435mice show decreased mRNA expression of several antioxidants
including MnSOD and catalase. Furthermore, ﬁbroblasts derived
from PGC-1α null mice display increased ROS levels and increased
susceptibility to oxidative stress-mediated cell death [60]. Therefore,
we hypothesized that another possible mechanism by which in-
creased mitochondrial content/biogenesis may provide protection
against apoptosis was by attenuating ROS production. In the present
investigation both MnSOD and catalase protein were elevated follow-
ing both SNAP and AICAR treatment, suggesting a possible protective
antioxidant effect. Surprisingly, there were no basal differences in
total cellular ROS (DCF ﬂuorescence) or mitochondrial superoxide
generation (MitoSOX ﬂuorescence) in biogenesis-induced cells.
Therefore, we suggest that the increased MnSOD and catalase protein
content observed likely reﬂect increases in PGC-1 signaling and/or
mitochondrial content (mass) as the change in these antioxidants is
consistent with the magnitude of PGC-1 activation as well as the in-
crease in mitochondrial content (as evident by MitoTracker ﬂuores-
cence and expression of non-antioxidant mitochondrial proteins
such as AIF). Regardless of the changes in MnSOD and catalase protein
in the biogenesis-induced myoblasts, the fact that both mitochondrial
superoxide and total cellular ROS were not different at a basal state or
following exposure to apoptotic stimuli strongly support the conclu-
sion that ROS-mediated mechanisms are not responsible for the
observed apoptotic protection.
Given that changes to apoptotic protein expression and redox status
likely do not account for the protective response we observed, alterna-
tive mechanisms are possible. It is well established that mitochondria
contribute to Ca2+ handling under physiological and pathological con-
ditions. In fact, mitochondria can act as “sinks” to buffer cellular Ca2+
[61], and mitochondrial Ca2+ load regulates the intrinsic apoptotic
pathway [62]. It has recently been shown that 4 days of AICAR and
DETA-NO (an NO donor) treatment in primary myoblast (which results
in increased mtDNA content), reduced cytosolic Ca2+ transients follow-
ing exposure to caffeine [63]. In addition, PGC-1α overexpression in
HeLa cells reduced mitochondrial Ca2+ uptake, as well as increased
cell survival to an apoptotic inducer that acts through mitochondrial
Ca2+ overload (C2-ceramide) but not independent of mitochondrial
Ca2+ overload (STS) [34]. In the present study we found that L6 myo-
blasts with increased mitochondrial content display decreased sensitiv-
ity to Ca2+-induced mitochondrial membrane depolarization and mPTP
formation. These data suggest that increasing cellular mitochondrial
content can improve cellular Ca2+ buffering capacity which would
prevent mitochondrial-mediated cell death signaling and apoptogenic
protein release, thereby preventing apoptotic cell death.
While we attribute the protective effect of SNAP and AICAR to an
increase in mitochondrial content, it is possible that protection
could be independent of mitochondrial biogenesis. However, the
acute nature of our treatment (5 h/day for 5 days) coupled with the
similar apoptotic protection observed with both AICAR and SNAP to
three distinct apoptosis-inducing agents, suggests a common mecha-
nism of protection. Moreover, our results are consistent with the
apoptotic protection observed during other in vivo and in vitromodels
of mitochondrial biogenesis or PGC-1 overexpression.
In summary, we demonstrate that modest increases in mitochon-
drial content in myoblasts at physiological levels (through two distinct
signaling agents) can provide protection against cell death from three
different inducing agents. Moreover, the increase in mitochondrial con-
tent was able to provide apoptotic protection against both caspase-
dependent and caspase-independent signaling mechanisms. These
protective effects were not due to changes in apoptotic-related protein
expression, nor to differences in mitochondrial or total ROS generation
but rather, due to a decreased sensitivity to Ca2+-induced mitochon-
drial membrane depolarization and mPTP formation. Ultimately,
these results advance our understanding of apoptotic signaling in skel-
etal muscle and represent a potential therapeutic approach in skeletal
muscle disorders displaying increased apoptosis.Acknowledgements
This research was supported by funds provided by the Natural
Sciences and Engineering Research Council of Canada (NSERC) to
Joe Quadrilatero.
References
[1] P. Saikumar, Z. Dong, V. Mikhailov, M. Denton, J.M. Weinberg, M.A. Venkatachalam,
Apoptosis: deﬁnition, mechanisms, and relevance to disease, Am. J. Med. 107
(1999) 489–506.
[2] J.C. Reed, Apoptosis-based therapies, Nat. Rev. Drug Discov. 1 (2002) 111–121.
[3] G. Kroemer, L. Galluzzi, P. Vandenabeele, J. Abrams, E.S. Alnemri, E.H. Baehrecke,
M.V. Blagosklonny, W.S. El-Deiry, P. Golstein, D.R. Green, M. Hengartner, R.A.
Knight, S. Kumar, S.A. Lipton, W. Malorni, G. Nuñez, M.E. Peter, J. Tschopp, J. Yuan,
M. Piacentini, B. Zhivotovsky, G. Melino, Classiﬁcation of cell death: recommenda-
tions of the Nomenclature Committee on Cell Death 2009, Cell Death Differ. 16
(2009) 3–11.
[4] J. Quadrilatero, S.E. Alway, E. Dupont-Versteegden, Skeletal muscle apoptotic
response to physical activity: potential mechanisms for protection, Appl. Physiol.
Nutr. Metab. 36 (2011) 608–617.
[5] I. Lavrik, A. Golks, P.H. Krammer, Death receptor signaling, J. Cell Sci. 118 (2005)
265–267.
[6] G. Kroemer, L. Galluzzi, C. Brenner, Mitochondrial membrane permeabilization in
cell death, Physiol. Rev. 87 (2007) 99–163.
[7] V.I. Rasheva, P.M. Domingos, Cellular responses to endoplasmic reticulum stress
and apoptosis, Apoptosis 14 (2009) 996–1007.
[8] S.W.G. Tait, D.R. Green, Mitochondria and cell death: outer membrane perme-
abilization and beyond, Nat. Rev. Mol. Cell Biol. 11 (2010) 621–632.
[9] P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri, X. Wang,
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex
initiates an apoptotic protease cascade, Cell 91 (1997) 479–489.
[10] C. Du, M. Fang, Y. Li, L. Li, X. Wang, Smac, a mitochondrial protein that promotes
cytochrome c-dependent caspase activation by eliminating IAP inhibition, Cell
102 (2000) 33–42.
[11] Q.L. Deveraux, R. Takahashi, G.S. Salvesen, J.C. Reed, X-linked IAP is a direct inhibitor
of cell-death proteases, Nature 388 (1997) 300–304.
[12] S.A. Susin, H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J. Mangion,
E. Jacotot, P. Costantini, M. Loefﬂer, N. Larochette, D.R. Goodlett, R. Aebersold, D.P.
Siderovski, J.M. Penninger, G. Kroemer, Molecular characterization of mitochondrial
apoptosis-inducing factor, Nature 397 (1999) 441–446.
[13] E. Daugas, S.A. Susin, N. Zamzami, K.F. Ferri, T. Irinopoulou, N. Larochette, M.C.
Prévost, B. Leber, D. Andrews, J. Penninger, G. Kroemer, Mitochondrio-nuclear
translocation of AIF in apoptosis and necrosis, FASEB J. 14 (2000) 729–739.
[14] Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S.
Cinti, B. Lowell, R.C. Scarpulla, B.M. Spiegelman, Mechanisms controlling mito-
chondrial biogenesis and respiration through the thermogenic coactivator
PGC-1, Cell 98 (1999) 115–124.
[15] J. Lin, H. Wu, P.T. Tarr, C. Zhang, Z. Wu, O. Boss, L.F. Michael, P. Puigserver, E.
Isotani, E.N. Olson, B.B. Lowell, R. Bassel-Duby, B.M. Spiegelman, Transcriptional
co-activator PGC-1α drives the formation of slow-twitch muscle ﬁbres, Nature
418 (2002) 797–801.
[16] D.A. Hood, Invited review: contractile activity-induced mitochondrial biogenesis
in skeletal muscle, J. Appl. Physiol. 90 (2001) 1137–1157.
[17] P.M. Siu, R.W. Bryner, J.K. Marty, S.E. Alway, Apoptotic adaptations from exercise
training in skeletal and cardiac muscles, FASEB J. 18 (2004) 1150–1152.
[18] W. Song, H. Kwak, J.M. Lawler, Exercise training attenuates age-induced changes
in apoptotic signaling in rat skeletal muscle, Antioxid. Redox Signal. 8 (2006)
517–528.
[19] E.M. McMillan, D.A. Graham, J.W.E. Rush, J. Quadrilatero, Decreased DNA frag-
mentation and apoptotic signaling in soleus muscle of hypertensive rats follow-
ing 6 weeks of treadmill training, J. Appl. Physiol. 113 (2012) 1048–1057.
[20] A. Safdar, J.M. Bourgeois, D.I. Ogborn, J.P. Little, B.P. Hettinga, M. Akhtar, J.E.
Thompson, S. Melov, N.J. Mocellin, G.C. Kujoth, T.A. Prolla, M.A. Tarnopolsky,
Endurance exercise rescues progeroid aging and induces systemic mitochondrial
rejuvenation in mtDNA mutator mice, Proc. Natl. Acad. Sci. U. S. A. 108 (2011)
4135–4140.
[21] K.L. Wicks, D.A. Hood, Mitochondrial adaptations in denervated muscle: relation-
ship to muscle performance, Am. J. Physiol. Cell Physiol. 260 (1991) C841–C850.
[22] B. Chabi, P.J. Adhihetty, M.F.N. O'Leary, K.J. Menzies, D.A. Hood, Relationship be-
tween SIRT1 expression and mitochondrial proteins during conditions of chronic
muscle use and disuse, J. Appl. Physiol. 107 (2009) 1730–1735.
[23] P.M. Siu, S.E. Alway, Mitochondria-associated apoptotic signalling in denervated
rat skeletal muscle, J. Physiol. 565 (2005) 309–323.
[24] C. Leeuwenburgh, C.M. Gurley, B.A. Strotman, E.E. Dupont-Versteegden, Age-related
differences in apoptosis with disuse atrophy in soleus muscle, Am. J. Physiol. Regul.
Integr. Comp. Physiol. 288 (2005) R1288–R1296.
[25] A.E. Civitarese, S. Carling, L.K. Heilbronn, M.H. Hulver, B. Ukropcova, W.A.
Deutsch, S.R. Smith, E. Ravussin, Calorie restriction increases muscle mitochon-
drial biogenesis in healthy humans, PLoS Med. 4 (2007) 485–494.
[26] F.M. Cerqueira, F.R.M. Laurindo, A.J. Kowaltowski, PLoS One 6 (2011).
[27] T. Phillips, C. Leeuwenburgh, Muscle ﬁber-speciﬁc apoptosis and TNF-α signaling
in sarcopenia are attenuated by life-long calorie restriction, FASEB J. (2005)
668–670.
3435A.D. Dam et al. / Biochimica et Biophysica Acta 1833 (2013) 3426–3435[28] A.J. Dirks, C. Leeuwenburgh, Aging and lifelong calorie restriction result in adaptations
of skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor
of apoptosis, caspase-3, and caspase-12, Free Radic. Biol. Med. 36 (2004) 27–39.
[29] O.E. Rooyackers, D.B. Adey, P.A. Ades, K.S. Nair, Effect of age on in vivo rates of mi-
tochondrial protein synthesis in human skeletal muscle, Proc. Natl. Acad. Sci. U. S.
A. 93 (1996) 15364–15369.
[30] K.R. Short, M.L. Bigelow, J. Kahl, R. Singh, J. Coenen-Schimke, S. Raghavakaimal,
K.S. Nair, Decline in skeletal muscle mitochondrial function with aging in
humans, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5618–5623.
[31] E.E. Pistilli, P.M. Siu, S.E. Alway, Molecular regulation of apoptosis in fast plantaris
muscles of aged rats, J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 245–255.
[32] G.K. McConell, G.P.Y. Ng, M. Phillips, Z. Ruan, S.L. Macaulay, G.D. Wadley, Central
role of nitric oxide synthase in AICAR and caffeine-induced mitochondrial biogene-
sis in L6 myocytes, J. Appl. Physiol. 108 (2010) 589–595.
[33] E. Nisoli, S. Falcone, C. Tonello, V. Cozzi, L. Palomba, M. Fiorani, A. Pisconti, S.
Brunelli, A. Cardile, M. Francolini, O. Cantoni, M.O. Carruba, S. Moncada, E.
Clementi, Mitochondrial biogenesis by NO yields functionally active mitochon-
dria in mammals, Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16507–16512.
[34] K. Bianchi, G. Vandecasteele, C. Carli, A. Romagnoli, G. Szabadkai, R. Rizzuto, Regulation
of Ca2+ signalling and Ca2+-mediated cell death by the transcriptional coactivator
PGC-1α, Cell Death Differ. 13 (2006) 586–596.
[35] P.M. Siu, Y. Wang, S.E. Alway, Apoptotic signaling induced by H2O2-mediated
oxidative stress in differentiated C2C12 myotubes, Life Sci. 84 (2009) 468–481.
[36] A.D. Dam, A.S. Mitchell, J.W.E. Rush, J. Quadrilatero, Elevated skeletal muscle ap-
optotic signaling following glutathione depletion, Apoptosis 17 (2012) 48–60.
[37] L. Galluzzi, N. Zamzami, T. de La Motte Rouge, C. Lemaire, C. Brenner, G. Kroemer,
Methods for the assessment of mitochondrial membrane permeabilization in
apoptosis, Apoptosis 12 (2007) 803–813.
[38] E.M. McMillan, J. Quadrilatero, Differential apoptosis-related protein expression, mi-
tochondrial properties, proteolytic enzyme activity, and DNA fragmentation between
skeletal muscles, Am. J. Physiol. Regul. Integr. Comp. Physiol. 300 (2011) R531–R543.
[39] N.J. Waterhouse, J.A. Trapani, A new quantitative assay for cytochrome c release
in apoptosis cells, Cell Death Differ. 10 (2003) 853–855.
[40] N.J. Waterhouse, R. Steel, R. Kluck, J.A. Trapani, Assaying cytochrome C translocation
during apoptosis, Methods Mol. Biol. 284 (2004) 307–313.
[41] D. Poncet, P. Boya, D. Métivier, N. Zamzami, G. Kroemer, Cytoﬂuorometric quan-
titation of apoptosis-driven inner mitochondrial membrane permeabilization,
Apoptosis 8 (2003) 521–530.
[42] P. Bernardi, L. Scorrano, R. Colonna, V. Petronilli, F. Di Lisa, Mitochondria and cell
death. Mechanistic aspects and methodological issues, Eur. J. Biochem. 264 (1999)
687–701.
[43] W.W. Winder, B.F. Holmes, D.S. Rubink, E.B. Jensen, M. Chen, J.O. Holloszy, Activa-
tion of AMP-activated protein kinase increases mitochondrial enzymes in skeletal
muscle, J. Appl. Physiol. 88 (2000) 2219–2226.
[44] E.O. Ojuka, T.E. Jones, D. Han, M. Chen, B.R. Wamhoff, M. Sturek, J.O. Holloszy,
Intermittent increases in cytosolic Ca2+ stimulate mitochondrial biogenesis in
muscle cells, Am. J. Physiol. Endocrinol. Metab. 283 (2002) E1040–E1045.
[45] E. Phielix, R. Meex, E. Moonen-Kornips, M.K.C. Hesselink, P. Schrauwen, Exercise
training increases mitochondrial content and ex vivo mitochondrial function
similarly in patients with type 2 diabetes and in control individuals, Diabetologia
53 (2010) 1714–1721.
[46] B.J. Gurd, Y. Yoshida, J.T. McFarlan, G.P. Holloway, C.D. Moyes, G.J.F. Heigenhauser,
L. Spriet, A. Bonen, Nuclear SIRT1 activity, but not protein content, regulatesmitochondrial biogenesis in rat and human skeletal muscle, Am. J. Physiol.
Regul. Integr. Comp. Physiol. 301 (2011) R67–R75.
[47] T. Wenz, S.G. Rossi, R.L. Rotundo, B.M. Spiegelman, C.T. Moraes, Increased muscle
PGC-1α expression protects from sarcopenia and metabolic disease during aging,
Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 20405–20410.
[48] S.M. Turpin, G.I. Lancaster, I. Darby, M.A. Febbraio, M.J. Watt, Apoptosis in skeletal
muscle myotubes is induced by ceramides and is positively related to insulin
resistance, Am. J. Physiol. Endocrinol. Metab. 291 (2006) E1341–E1350.
[49] Y. Cámara, C. Duval, B. Sibille, F. Villarroya, Activation of mitochondrial-driven
poptosis in skeletal muscle cells is not mediated by reactive oxygen species pro-
duction, Int. J. Biochem. Cell Biol. 39 (2007) 146–160.
[50] S.W. Yu, H. Wang, M.F. Poitras, C. Coombs, W.J. Bowers, H.J. Federoff, G.G. Poirier,
T.M. Dawson, V.L. Dawson, Mediation of poly(ADP-ribose) polymerase-1-
dependent cell death by apoptosis-inducing factor, Science 297 (2002) 259–263.
[51] Y. Son, Y. Jang, J. Heo, W. Chung, K. Choi, J. Lee, Apoptosis-inducing factor plays a
critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-
exposed cells, Apoptosis 14 (2009) 796–808.
[52] E. Norberg, S. Orrenius, B. Zhivotovsky, Mitochondrial regulation of cell death:
processing of apoptosis-inducing factor (AIF), Biochem. Biophys. Res. Commun.
396 (2010) 95–100.
[53] N. Modjtahedi, F. Giordanetto, F. Madeo, G. Kroemer, Apoptosis-inducing factor:
vital and lethal, Trends Cell Biol. 16 (2006) 264–272.
[54] E. Norberg, V. Gogvadze, H. Vakifahmetoglu, S. Orrenius, B. Zhivotovsky, Oxida-
tive modiﬁcation sensitizes mitochondrial apoptosis-inducing factor to calpain-
mediated processing, Free Radic. Biol. Med. 48 (2010) 791–797.
[55] G. López-Lluch, N. Hunt, B. Jones, M. Zhu, H. Jamieson, S. Hilmer, M.V. Cascajo, J.
Allard, D.K. Ingram, P. Navas, R. De Cabo, Calorie restriction induces mitochondri-
al biogenesis and bioenergetic efﬁciency, Proc. Natl. Acad. Sci. U. S. A. 103 (2006)
1768–1773.
[56] L. Bevilacqua, J.J. Ramsey, K. Hagopian, R. Weindruch, M.E. Harper, Long-term ca-
loric restriction increases UCP3 content but decreases proton leak and reactive
oxygen species production in rat skeletal muscle mitochondria, Am. J. Physiol.
Endocrinol. Metab. 289 (2005) E429–E438.
[57] P. Venditti, P. Masullo, S. Di Meo, Effect of training on H2O2 release by mitochon-
dria from rat skeletal muscle, Arch. Biochem. Biophys. 372 (1999) 315–320.
[58] S. Servais, K. Couturier, H. Koubi, J.L. Rouanet, D. Desplanches, M.H. Sornay-Mayet,
B. Sempore, J.M. Lavoie, R. Favier, Effect of voluntary exercise on H2O2 release by
subsarcolemmal and intermyoﬁbrillar mitochondria, Free Radic. Biol. Med. 35
(2003) 24–32.
[59] C. Kang, L.L. Ji, Role of PGC-1α signaling in skeletal muscle health and disease,
Ann. N. Y. Acad. Sci. 1271 (2012) 110–117.
[60] J. St-Pierre, S. Drori, M. Uldry, J.M. Silvaggi, J. Rhee, S. Jäger, C. Handschin, K.
Zheng, J. Lin, W. Yang, D.K. Simon, R. Bachoo, B.M. Spiegelman, Suppression of re-
active oxygen species and neurodegeneration by the PGC-1 transcriptional
coactivators, Cell 127 (2006) 397–408.
[61] V. Romanello, M. Sandri, Mitochondrial biogenesis and fragmentation as regula-
tors of muscle protein degradation, Curr. Hypertens. Rep. 12 (2010) 433–439.
[62] G. Szabadkai, A.M. Simoni, M. Chami, M.R. Wieckowski, R.J. Youle, R. Rizzuto, Drp-
1-dependent division of the mitochondrial network blocks intraorganellar Ca2+
waves and protects against Ca2+-mediated apoptosis, Mol. Cell. 16 (2004) 59–68.
[63] S. Ding, J.R. Contrevas, A.Y. Abramov, Z. Qi, M.R. Duchen, Mild stress of caffeine in-
creased mtDNA content in skeletal muscle cells: the interplay between Ca2+
transients and nitric oxide, J. Muscle Res. Cell Motil. (2012) 1–11.
